ArticleBlood advances2021

Anti-inflammatory treatment in MPN: targeting TNFR1 and TNFR2 in JAK2-V617F-induced disease.

Peter Müller et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.